Terms: = Liver cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17
11 results:
1. LAMC2 mitigates ER stress by enhancing ER-mitochondria interaction via binding to myh9 and MYH10.
Tong D; Zhou J; Zhou J; Wang X; Gao B; Rui X; Liu L; Chen Q; Huang C
Cancer Gene Ther; 2024 Jan; 31(1):43-57. PubMed ID: 37891404
[TBL] [Abstract] [Full Text] [Related]
2. TM4SF1 upregulates myh9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC.
Yang SB; Zhou ZH; Lei J; Li XW; Chen Q; Li B; Zhang YW; Ge YZ; Zuo S
Biol Direct; 2023 Apr; 18(1):18. PubMed ID: 37069693
[TBL] [Abstract] [Full Text] [Related]
3. NAP1L5 targeting combined with myh9 Inhibit HCC progression through PI3K/AKT/mTOR signaling pathway.
Zhao R; Ge Y; Gong Y; Li B; Xiao B; Zuo S
Aging (Albany NY); 2022 Nov; 14(22):9000-9019. PubMed ID: 36374212
[TBL] [Abstract] [Full Text] [Related]
4. Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
Cui D; Cui X; Xu X; Zhang W; Yu Y; Gao Y; Mei C; Zheng W
BMC Cancer; 2022 Sep; 22(1):1027. PubMed ID: 36175877
[TBL] [Abstract] [Full Text] [Related]
5. Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis.
Xie C; Wang FY; Sang Y; Chen B; Huang JH; He FJ; Li H; Zhu Y; Liu X; Zhuang SM; Fang JH
Cancer Res; 2022 Jul; 82(13):2431-2443. PubMed ID: 35544764
[TBL] [Abstract] [Full Text] [Related]
6. ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/myh9/USP7/c-Myc axis.
Hou R; Li Y; Luo X; Zhang W; Yang H; Zhang Y; Liu J; Liu S; Han S; Liu C; Huang Y; Liu Z; Li A; Fang W
Int J Biol Sci; 2022; 18(6):2553-2567. PubMed ID: 35414777
[TBL] [Abstract] [Full Text] [Related]
7. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA.
Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X
FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778
[TBL] [Abstract] [Full Text] [Related]
8. Silencing myh9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
[TBL] [Abstract] [Full Text] [Related]
9. LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/myh9 axis.
Liu T; Liu Y; Wei C; Yang Z; Chang W; Zhang X
Biomed Pharmacother; 2020 Jan; 121():109607. PubMed ID: 31726371
[TBL] [Abstract] [Full Text] [Related]
10. Targeting Mechanoresponsive Proteins in Pancreatic cancer: 4-Hydroxyacetophenone Blocks Dissemination and Invasion by Activating MYH14.
Surcel A; Schiffhauer ES; Thomas DG; Zhu Q; DiNapoli KT; Herbig M; Otto O; West-Foyle H; Jacobi A; Kräter M; Plak K; Guck J; Jaffee EM; Iglesias PA; Anders RA; Robinson DN
Cancer Res; 2019 Sep; 79(18):4665-4678. PubMed ID: 31358530
[TBL] [Abstract] [Full Text] [Related]
11. HMG CoA reductase inhibitors (statins) for dialysis patients.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
[TBL] [Abstract] [Full Text] [Related]
